Pharmacologic Therapies for Obesity
- 31 March 2010
- journal article
- review article
- Published by Elsevier BV in Gastroenterology Clinics of North America
- Vol. 39 (1), 69-79
- https://doi.org/10.1016/j.gtc.2010.01.001
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Combination therapy for obesity and metabolic diseaseCurrent Opinion in Endocrinology, Diabetes and Obesity, 2009
- Naltrexone for the treatment of obesity: review and updateExpert Opinion on Pharmacotherapy, 2009
- Bupropion and naltrexone: a review of their use individually and in combination for the treatment of obesityExpert Opinion on Pharmacotherapy, 2009
- Current pharmacotherapeutic concepts for the treatment of obesity in adultsTherapeutic Advances in Cardiovascular Disease, 2009
- Pharmacotherapy of obesity: emerging drugs and targetsEmerging Therapeutic Targets, 2008
- Lifestyle and Pharmacological Approaches to Weight Loss: Efficacy and SafetyJournal of Clinical Endocrinology & Metabolism, 2008
- Sustained Weight Loss Following 12-Month Pramlintide Treatment as an Adjunct to Lifestyle Intervention in ObesityDiabetes Care, 2008
- Head‐to‐head studies evaluating efficacy of pharmaco‐therapy for obesity: a systematic review and meta‐analysisObesity Reviews, 2008
- Weight loss and metabolic effects of topiramate in overweight and obese type 2 diabetic patients: randomized double-blind placebo-controlled trialInternational Journal of Obesity, 2007
- Valvular Heart Disease Associated with Fenfluramine–PhentermineNew England Journal of Medicine, 1997